Clinical Trials

A Randomized Controlled Trial of Prostatak as Adjuvant to Up-Front Radiation Therapy of Localized Prostate Cancer

Study ID
Advantagene PrTK03

NCT Number
NCT01436968 (Click on the NCT number for more information about the trial)

Research Study Number

Principle Investigator
Dr. Glen Gejerman


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at

Apply Now